185 related articles for article (PubMed ID: 25477145)
1. Exact calculation of power and sample size in bioequivalence studies using two one-sided tests.
Shen M; Russek-Cohen E; Slud EV
Pharm Stat; 2015; 14(2):95-101. PubMed ID: 25477145
[TBL] [Abstract][Full Text] [Related]
2. A simple formula for sample size calculation in equivalence studies.
Zhang P
J Biopharm Stat; 2003 Aug; 13(3):529-38. PubMed ID: 12921399
[TBL] [Abstract][Full Text] [Related]
3. Sample size determination for equivalence assessment with multiple endpoints.
Sun A; Dong X; Tsong Y
J Biopharm Stat; 2014; 24(6):1203-14. PubMed ID: 25032845
[TBL] [Abstract][Full Text] [Related]
4. An approach for sample size determination of average bioequivalence based on interval estimation.
Chiang C; Hsiao CF
Stat Med; 2017 Mar; 36(7):1068-1082. PubMed ID: 28070984
[TBL] [Abstract][Full Text] [Related]
5. Multiple testing for bioequivalence with pharmacokinetic data in 2 x 2 crossover designs.
Chen YI; Huang CS
Stat Med; 2009 Dec; 28(28):3567-79. PubMed ID: 19760611
[TBL] [Abstract][Full Text] [Related]
6. A two one-sided tests procedure for assessment of individual bioequivalence.
Liu J; Chow SC
J Biopharm Stat; 1997 Mar; 7(1):49-61. PubMed ID: 9056588
[TBL] [Abstract][Full Text] [Related]
7. An approximate approach to sample size determination in bioequivalence testing with multiple pharmacokinetic responses.
Tsai CA; Huang CY; Liu JP
Stat Med; 2014 Aug; 33(19):3300-17. PubMed ID: 24771655
[TBL] [Abstract][Full Text] [Related]
8. A note on sample size determination for bioequivalence studies with high-order crossover designs.
Chen KW; Chow SC; Li G
J Pharmacokinet Biopharm; 1997 Dec; 25(6):753-65. PubMed ID: 9697082
[TBL] [Abstract][Full Text] [Related]
9. Equivalence assessment for interchangeability based on two-sided tests.
Dong X; Tsong Y
J Biopharm Stat; 2014; 24(6):1312-31. PubMed ID: 25032976
[TBL] [Abstract][Full Text] [Related]
10. Equivalence tests for interchangeability based on two one-sided probabilities.
Dong X; Tsong Y; Shen M
J Biopharm Stat; 2014; 24(6):1332-48. PubMed ID: 25033074
[TBL] [Abstract][Full Text] [Related]
11. Sample size determination in bioequivalence studies using statistical assurance.
Ring A; Lang B; Kazaroho C; Labes D; Schall R; Schütz H
Br J Clin Pharmacol; 2019 Oct; 85(10):2369-2377. PubMed ID: 31276603
[TBL] [Abstract][Full Text] [Related]
12. Letter to the editor by the authors of Exact Calculation of Power and Sample Size in Bioequivalence Studies Using Two One-sided Tests, Pharmaceutical Statistics, DOI: 10.1002/pst.1666.
Shen M; Russek-Cohen E; Slud EV
Pharm Stat; 2015; 14(3):272. PubMed ID: 25807931
[TBL] [Abstract][Full Text] [Related]
13. Average bioequivalence for two-sequence two-period crossover design with incomplete data.
Lee JY; Kim BC; Park SG
J Biopharm Stat; 2005; 15(5):857-67. PubMed ID: 16078389
[TBL] [Abstract][Full Text] [Related]
14. Power of the two one-sided tests procedure in bioequivalence.
Phillips KF
J Pharmacokinet Biopharm; 1990 Apr; 18(2):137-44. PubMed ID: 2348380
[TBL] [Abstract][Full Text] [Related]
15. A note on sample size calculation for mean comparisons based on noncentral t-statistics.
Chow SC; Shao J; Wang H
J Biopharm Stat; 2002 Nov; 12(4):441-56. PubMed ID: 12477068
[TBL] [Abstract][Full Text] [Related]
16. Robust and bootstrap testing procedures for bioequivalence.
Shen CF; Iglewicz B
J Biopharm Stat; 1994 Mar; 4(1):65-90. PubMed ID: 8019585
[TBL] [Abstract][Full Text] [Related]
17. On statistical power for average bioequivalence testing under replicated crossover designs.
Wan H; Chow SC
J Biopharm Stat; 2002 Aug; 12(3):295-309. PubMed ID: 12448572
[TBL] [Abstract][Full Text] [Related]
18. Sample size determination in two-sided distribution-free treatment versus control multiple comparisons.
Fan C; Zhang D
J Biopharm Stat; 2013; 23(6):1308-29. PubMed ID: 24138434
[TBL] [Abstract][Full Text] [Related]
19. Sample size calculation for the Power Model for dose proportionality studies.
Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
[TBL] [Abstract][Full Text] [Related]
20. A comparison of group sequential and fixed sample size designs for bioequivalence trials with highly variable drugs.
Knahl SIE; Lang B; Fleischer F; Kieser M
Eur J Clin Pharmacol; 2018 May; 74(5):549-559. PubMed ID: 29362819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]